Celsius (NASDAQ:CELH - Free Report) had its price objective decreased by LADENBURG THALM/SH SH from $62.00 to $58.00 in a research report report published on Thursday morning,Benzinga reports. LADENBURG THALM/SH SH currently has a neutral rating on the stock.
Other equities research analysts also recently issued reports about the company. Stifel Nicolaus decreased their price target on Celsius from $45.00 to $37.00 and set a "buy" rating for the company in a report on Monday, February 10th. TD Cowen cut Celsius from a "buy" rating to a "hold" rating and reduced their price target for the company from $40.00 to $29.00 in a report on Wednesday, January 22nd. Morgan Stanley restated an "equal weight" rating and set a $42.00 target price on shares of Celsius in a research report on Thursday, December 26th. Piper Sandler cut their price target on shares of Celsius from $47.00 to $33.00 and set an "overweight" rating for the company in a report on Thursday, January 23rd. Finally, Needham & Company LLC boosted their price objective on shares of Celsius from $38.00 to $40.00 and gave the stock a "buy" rating in a report on Tuesday, February 25th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and twelve have issued a buy rating to the company's stock. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average target price of $45.00.
Read Our Latest Research Report on Celsius
Celsius Stock Up 5.9 %
NASDAQ:CELH traded up $1.97 during trading hours on Thursday, reaching $35.62. 15,026,742 shares of the company's stock were exchanged, compared to its average volume of 7,516,973. The firm has a market capitalization of $8.38 billion, a price-to-earnings ratio of 80.96, a P/E/G ratio of 2.90 and a beta of 1.90. Celsius has a 1-year low of $21.10 and a 1-year high of $98.85. The company has a 50-day moving average of $26.86 and a 200 day moving average of $28.77.
Celsius (NASDAQ:CELH - Get Free Report) last announced its earnings results on Thursday, February 20th. The company reported $0.14 earnings per share for the quarter, topping the consensus estimate of $0.11 by $0.03. The business had revenue of $332.20 million during the quarter, compared to the consensus estimate of $326.07 million. Celsius had a net margin of 10.70% and a return on equity of 51.89%. Research analysts forecast that Celsius will post 0.89 EPS for the current fiscal year.
Insiders Place Their Bets
In other news, insider Paul H. Storey sold 10,188 shares of the stock in a transaction dated Thursday, March 6th. The shares were sold at an average price of $25.77, for a total transaction of $262,544.76. Following the transaction, the insider now directly owns 45,297 shares in the company, valued at $1,167,303.69. This represents a 18.36 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Joyce Russell sold 4,000 shares of the company's stock in a transaction that occurred on Tuesday, March 11th. The stock was sold at an average price of $28.47, for a total transaction of $113,880.00. Following the transaction, the director now directly owns 19,106 shares of the company's stock, valued at $543,947.82. This trade represents a 17.31 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 2.20% of the company's stock.
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently modified their holdings of CELH. HM Payson & Co. lifted its holdings in Celsius by 122.2% in the 4th quarter. HM Payson & Co. now owns 1,000 shares of the company's stock worth $26,000 after buying an additional 550 shares in the last quarter. S.A. Mason LLC lifted its stake in shares of Celsius by 100.0% in the fourth quarter. S.A. Mason LLC now owns 1,400 shares of the company's stock worth $37,000 after acquiring an additional 700 shares in the last quarter. GAMMA Investing LLC grew its stake in Celsius by 185.7% during the 4th quarter. GAMMA Investing LLC now owns 1,714 shares of the company's stock valued at $45,000 after purchasing an additional 1,114 shares in the last quarter. Blue Trust Inc. increased its holdings in Celsius by 32.8% during the 4th quarter. Blue Trust Inc. now owns 1,786 shares of the company's stock worth $47,000 after purchasing an additional 441 shares during the last quarter. Finally, Knuff & Co LLC purchased a new position in shares of Celsius during the 4th quarter valued at approximately $50,000. Institutional investors and hedge funds own 60.95% of the company's stock.
Celsius Company Profile
(
Get Free Report)
Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.
Further Reading

Before you consider Celsius, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Celsius wasn't on the list.
While Celsius currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.